Monday, November 2, 2026: 10 items, 0 changes to existing records.

Lead items first, each with why it was picked. Built by the knowledge layer from its change log.

Lead

NewDOI 10.1245/s10434-026-20549-9 ↗ paper
ASO Visual Abstract: KRAS and TP53 Circulating Tumor DNA are Prognostic in Localized Pancreatic Cancer.
Why it was picked: most recent in the fixture set (novelty scoring arrives with study cards)
NewNCT07859085 ↗ trial
A Study to Evaluate the Safety and Activity of GDC-7035 With Anti-Cancer Therapies in Participants With KRAS G12D-Mutated Unresectable Advanced or Metastatic Colorectal Cancer or Pancreatic Ductal Adenocarcinoma
Why it was picked: most recent in the fixture set (novelty scoring arrives with study cards)
NewDOI 10.1186/s13045-026-01863-x ↗ paper
KRAS in pancreatic cancer: from molecular biology to transformative therapeutics.
Why it was picked: most recent in the fixture set (novelty scoring arrives with study cards)
NewNCT07903415 ↗ trial
A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.
Why it was picked: most recent in the fixture set (novelty scoring arrives with study cards)
NewDOI 10.1158/0008-5472.can-26-4570 ↗ paper
Opening the window for immunotherapy in pancreatic cancer.
Why it was picked: most recent in the fixture set (novelty scoring arrives with study cards)

Also

Not in the data yet: changes to existing records. Status changes, newly posted results and retractions need the change log and versioned records (knowledge gap K2). Until then the digest lists new records only.